Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators.

Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21.

2.

Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction.

Sharma S, Venkitaraman R, Vas PR, Rayman G.

Brain Behav. 2015 Jul;5(7):e00354. doi: 10.1002/brb3.354. Epub 2015 May 26.

3.

A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer.

Venkitaraman R, Lorente D, Murthy V, Thomas K, Parker L, Ahiabor R, Dearnaley D, Huddart R, De Bono J, Parker C.

Eur Urol. 2015 Apr;67(4):673-9. doi: 10.1016/j.eururo.2014.10.004. Epub 2014 Oct 16.

PMID:
25457497
4.

Breast-cancer adjuvant therapy with zoledronic acid.

Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators.

N Engl J Med. 2011 Oct 13;365(15):1396-405. doi: 10.1056/NEJMoa1105195. Epub 2011 Sep 25.

5.

Does one size fit all? Is there a standard radiation dose for malignant spinal cord compression?

Venkitaraman R.

J Support Oncol. 2011 Jul-Aug;9(4):127-8. No abstract available.

PMID:
21809515
6.

Lobular neoplasia of the breast.

Venkitaraman R.

Breast J. 2010 Sep-Oct;16(5):519-28. doi: 10.1111/j.1524-4741.2010.00971.x. Epub 2010 Aug 4. Review.

PMID:
20701604
7.

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.

Cook GJ, Venkitaraman R, Sohaib AS, Lewington VJ, Chua SC, Huddart RA, Parker CC, Dearnaley DD, Horwich A.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):7-13. doi: 10.1007/s00259-010-1576-0. Epub 2010 Aug 10.

PMID:
20697891
8.

Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.

Johnson C, Fitzsimmons D, Gilbert J, Arrarras JI, Hammerlid E, Bredart A, Ozmen M, Dilektasli E, Coolbrandt A, Kenis C, Young T, Chow E, Venkitaraman R, Howse F, George S, O'Connor S, Yadegarfar G; EORTC Quality of Life Group.

Eur J Cancer. 2010 Aug;46(12):2242-52. doi: 10.1016/j.ejca.2010.04.014. Epub 2010 May 23. Review.

PMID:
20580993
9.

Late solitary testicular metastasis from rectal cancer.

Venkitaraman R, George M, Weerasooriya S, Selva-Nayagam S.

J Cancer Res Ther. 2010 Jan-Mar;6(1):89-91. doi: 10.4103/0973-1482.63562.

10.

Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance.

Venkitaraman R, Thomas K, Grace P, Dearnaley DP, Horwich A, Huddart RA, Parker CC.

Tumour Biol. 2010 Apr;31(2):97-102. doi: 10.1007/s13277-009-0013-0. Epub 2010 Feb 16.

PMID:
20358422
11.

Metastatic spinal cord compression: review of the evidence for a radiotherapy dose fractionation schedule.

Prewett S, Venkitaraman R.

Clin Oncol (R Coll Radiol). 2010 Apr;22(3):222-30. doi: 10.1016/j.clon.2010.01.006. Epub 2010 Feb 6.

PMID:
20138487
12.

Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.

Venkitaraman R.

Expert Rev Anticancer Ther. 2010 Feb;10(2):199-207. doi: 10.1586/era.09.189. Review.

PMID:
20131996
13.

Frequency of screening magnetic resonance imaging to detect occult spinal cord compromise and to prevent neurological deficit in metastatic castration-resistant prostate cancer.

Venkitaraman R, Sohaib SA, Barbachano Y, Parker CC, Huddart RA, Horwich A, Dearnaley D.

Clin Oncol (R Coll Radiol). 2010 Mar;22(2):147-52. doi: 10.1016/j.clon.2009.11.007. Epub 2010 Jan 12.

PMID:
20034772
14.

Prognosis of patients with triple-negative breast cancer and brain metastasis.

Venkitaraman R, Joseph T, Dhadda A, Chaturvedi A, Upadhyay S.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):729-30. doi: 10.1016/j.clon.2009.07.002. Epub 2009 Jul 29. No abstract available.

PMID:
19643588
15.

Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

Venkitaraman R, Cook GJ, Dearnaley DP, Parker CC, Khoo V, Eeles R, Huddart RA, Horwich A, Sohaib SA.

J Med Imaging Radiat Oncol. 2009 Jun;53(3):241-7. doi: 10.1111/j.1754-9485.2009.02070.x.

PMID:
19624290
16.

Results of combined modality treatment for nasopharyngeal cancer.

Venkitaraman R, Ramanan SG, Vasanthan A, Sagar TG.

J Cancer Res Ther. 2009 Apr-Jun;5(2):102-6. doi: 10.4103/0973-1482.52798.

17.

Is electroglottography-based videostroboscopic assessment of post-laryngectomy prosthetic speech useful?

Kazi RA, Singh A, Venkitaraman R, Sayed SI, Rhys-Evans P, Harrington KJ.

J Cancer Res Ther. 2009 Apr-Jun;5(2):85-92. doi: 10.4103/0973-1482.52792.

18.

Primary Adult Renal Ewing's Sarcoma: A Rare Entity.

Mukkunda R, Venkitaraman R, Thway K, Min T, Fisher C, Horwich A, Judson I.

Sarcoma. 2009;2009:504654. doi: 10.1155/2009/504654. Epub 2009 May 26.

19.

Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?

Venkitaraman R, Cook GJ, Dearnaley DP, Parker CC, Huddart RA, Khoo V, Eeles R, Horwich A, Sohaib SA.

Clin Oncol (R Coll Radiol). 2009 Feb;21(1):39-42. doi: 10.1016/j.clon.2008.09.006. Epub 2008 Nov 6.

PMID:
18993040
20.

Baseline urinary phytoestrogen levels and the natural history of untreated, localised prostate cancer in a British population.

Venkitaraman R, Thomas K, Grace P, Dearnaley D, Horwich A, Huddart R, Parker CC.

Int J Biol Markers. 2008 Jul-Sep;23(3):192-7.

PMID:
18949747

Supplemental Content

Loading ...
Support Center